NEW YORK (Reuters) - Johnson & Johnson
However, the talks were characterized as fragile and could fall apart at any time, one person told the Journal.
Continue Reading Below
Synthes shares closed up 6.2 percent in Switzerland, with traders citing market talk that the diversified healthcare company or U.S. medical device maker Medtronic Inc
J&J declined to comment on the report. "As a matter of policy we don't comment on speculation," J&J spokesman Bill Price said.
(Reporting by Bill Berkrot and Lewis Krauskopf; Editing by Richard Chang)